# Universal Health Services Inc. (UHS) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $169.65, market value $10.0 billion.

## Valuation
- **P/E (trailing): 6.9×** (5-yr avg 12.1×, 3-yr avg 11.6×). Universal Health Services Inc. trades at 6.9× trailing earnings, well below its own five-year average of 12.1×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 7.1×, higher than trailing, so analysts expect earnings to fall.
- **PEG: 0.19**. A PEG of 0.19 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.6×**. Each dollar of revenue is priced at 0.6×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.3×**. The shares trade at 1.3× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 5.4×**. Enterprise value is 5.4× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 8.5%** (5-yr avg 4.6%). Free cash flow equals 8.5% of the market value, above its five-year average of 4.6%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 14.4%**. The inverse of the P/E: 14.4% of the price is earned each year.

## Profitability
- **Operating margin: 11.4%**. 11.4% of revenue is left after running the business.
- **Net margin: 8.6%**. 8.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 20.5%**. 20.5% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on invested capital: 13.7%**. Return on all capital, debt included, is 13.7%.
- **Return on assets: 9.8%**. Each dollar of assets produces 9.8% of profit.

## Growth
- **Revenue growth (1 yr): 9.7%** (3-yr 9.0%/yr, 5-yr 8.5%/yr). Revenue grew 9.7% over the last year, against 8.5% a year compounded over five years.
- **EPS growth (1 yr): 37.3%** (3-yr 36.2%/yr, 5-yr 16.0%/yr). Earnings per share rose 37.3%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 48.0%/yr**. Free cash flow has compounded at 48.0% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.65**. Debt is 0.65 times equity, moderate leverage.
- **Net debt / EBITDA: 1.7×**. It would take 1.7 years of operating earnings to repay net borrowings, within the comfortable range.
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 0.47%** ($0.80 per share, trailing). Universal Health Services Inc. yields 0.47%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 3%** (6% of free cash flow). 3% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 5**. 5 straight years of increases.
- **Dividend growth (5 yr): 32.0%/yr** (1-yr 0.0%). The dividend has compounded at 32.0% a year over five years, doubling roughly every 2 years at that pace.

## Analyst view
- **Analyst consensus: buy** (17 analysts). 17 analysts cover Universal Health Services Inc.; the consensus is buy, with an average price target of $193.65 (+14% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -8.3%** (YTD -22.0%, 3-mo 17.0%). The shares are down 8.3% over twelve months including dividends.
- **From 52-week high: -31.1%** (21.1% above the low). Trading 31% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 51**. An RSI of 51 is neutral.
- **Beta (1 yr): 0.24** (volatility 32%). Beta of 0.24 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=UHS · Page: https://foliofundamentals.com/stocks/uhs

Not investment advice.